Search Results

Agricola

Record details

An inhalable nanoparticle enabling virulence factor elimination and antibiotics delivery for pneumococcal pneumonia therapy.

• Authors : Dong H; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.; Zhao Y

Subjects: Pneumonia, Pneumococcal*/Pneumonia, Pneumococcal*/Pneumonia, Pneumococcal*/drug therapy ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/administration & dosage ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/therapeutic use

• Source: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2024 Nov; Vol. 375, pp. 698-711. Date of Electronic Publication: 2024 Sep 25.Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet

Record details

High-performance lung-targeted bio-responsive platform for severe colistin-resistant bacterial pneumonia therapy.

• Authors : Cheng D; Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er Road, Shanghai, 200025, China.; Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

• Source: Bioactive materials [Bioact Mater] 2024 Feb 21; Vol. 35, pp. 517-533. Date of Electronic Publication: 2024 Feb 21 (Print Publication: 2024).Publisher: Ke Ai Publishing Country of Publication: China NLM ID: 101685294 Publication Model: eCollection Cited Medium: Internet ISSN: 2452-199X

Record details

Inflammation and Microbiota Regulation Potentiate Pneumonia Therapy by Biomimetic Bacteria and Macrophage Membrane Nanosystem.

• Authors : Li Y; School of Materials Science and Engineering, Peking University, Beijing 100871, China.; The Key Laboratory of Advanced Ceramics and Machining Technology by the Ministry of Education of China, School of Materials Science and Engineering, Tianjin University, Tianjin 300072, China.

• Source: Research (Washington, D.C.) [Research (Wash D C)] 2023; Vol. 6, pp. 0096. Date of Electronic Publication: 2023 Mar 27.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101747148 Publication Model: Print-Electronic

Record details

Investigators from Weifang Medical University Release New Data on Bacterial Pneumonia (Peptide-based Nano-antibiotic Transformers With Antibiotic Adjuvant Effect for Multidrug Resistant Bacterial Pneumonia Therapy)

• Source: Obesity, Fitness & Wellness Week. July 16, 2022, 3161

Record details

An inflammation-targeted nanoparticle with bacteria forced release of polymyxin B for pneumonia therapy.

• Authors : Zhang P; Beijing Advanced Innovation Centre for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, PR China. .; Ouyang Q

Subjects: Pneumonia*/Pneumonia*/Pneumonia*/drug therapy ; Nanoparticles*/Nanoparticles*/Nanoparticles*/therapeutic use; Humans

• Source: Nanoscale [Nanoscale] 2022 Oct 27; Vol. 14 (41), pp. 15291-15304. Date of Electronic Publication: 2022 Oct 27.Publisher: RSC Pub Country of Publication: England NLM ID: 101525249 Publication Model: Electronic Cited Medium: Internet ISSN: 2040-3372

Record details

Inflammation-modulating nanoparticles for pneumonia therapy.

• Authors : Muhammad W; MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, China.; Zhai Z

Subjects: Acute Lung Injury*/Acute Lung Injury*/Acute Lung Injury*/drug therapy ; Acute Lung Injury*/Acute Lung Injury*/Acute Lung Injury*/pathology ; Nanoparticles*/Nanoparticles*/Nanoparticles*/therapeutic use

• Source: Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology [Wiley Interdiscip Rev Nanomed Nanobiotechnol] 2022 Mar; Vol. 14 (2), pp. e1763. Date of Electronic Publication: Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101508311 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Impact of a Pharmacist-Driven MRSA Nasal PCR Protocol on Pneumonia Therapy.

• Authors : Pham SN; Department of Pharmacy Services, Mercy Health Saint Mary's, Grand Rapids, MI, USA.; Sturm AC

• Source: Hospital pharmacy [Hosp Pharm] 2021 Aug; Vol. 56 (4), pp. 221-227. Date of Electronic Publication: 2019 Nov 15.Publisher: Sage Publications Country of Publication: United States NLM ID: 0043175 Publication Model: Print-Electronic Cited Medium: Print ISSN:

Record details

Nosopharm developing nosocomial pneumonia therapy

• Source: R & D Focus Drug News. March 25, 2020

Record details

Nosopharm developing bacterial pneumonia therapy

• Source: R & D Focus Drug News. March 25, 2020

Record details